The Business Of CNS with Acumen's Jim Doherty, Ph.D.
Business Of Biotech
Timelines and Next Steps in Phase Two Studies
This chapter outlines the timeline for a phase two study's enrollment completion by mid-2025 and reviews the forthcoming results of a subcutaneous administration study expected in early 2025. It concludes with thoughts on an exciting industry event, emphasizing the enthusiasm surrounding these gatherings.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
